What is Aisteth?
Ai Health Highway, operating under the name Aisteth, is an AI-first company dedicated to making chronic disease screening cost-effective within primary care clinics. Their flagship product, AiSteth, is an AI-enabled smart stethoscope designed to screen, detect, and predict heart and lung disorders. This innovative technology leverages state-of-the-art signal processing and machine learning capabilities to enhance diagnostic accuracy and accessibility in healthcare.
How much funding has Aisteth raised?
Aisteth has raised a total of $1.5M across 1 funding round:
Series A
$1.5M
Series A (2024): $1.5M with participation from BiocytiH Foundation, The Chennai Angels, and Rainmatter Capital
Key Investors in Aisteth
BiocytiH Foundation
BiocytiH Foundation is an initiative focused on advancing interdisciplinary cyber-physical systems through research and development, entrepreneurship, and infrastructure development, offering incubation, training, and support for startups in biology, electronics, and computer science.
The Chennai Angels
The Chennai Angels (TCA) is an angel investment group in India comprising over 140 members dedicated to funding early-stage startups, providing capital, mentorship, and valuable insights to entrepreneurs across various sectors.
Rainmatter Capital
Rainmatter by Zerodha is an Indian fintech and health fund that supports Indian founders improving financial and health choices, providing funding and mentorship to startups in fintech, climate, health, and media.
What's next for Aisteth?
The substantial enterprise-level backing and recent strategic investment signal Aisteth's transition into a scaling phase. This capital infusion is expected to fuel product development, expand market reach, and potentially drive further innovation in AI-driven diagnostics. The company's focus on cost-effective screening in primary care positions it to address a critical need in global health, suggesting a future focused on widespread adoption and impact.
See full Aisteth company page
